Edwards Lifesciences, US28176E1082

Edwards Lifesciences stock heads into the open after a 1.26 percent gain

Published on 09/23/2026 at 06:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Edwards Lifesciences stock reached USD 89.45 on the NYSE, trading between USD 88.49 and USD 89.58 as the Nasdaq Composite gained 0.45 percent.

Fotorealistisches Katheterlabor mit Chirurgenteam bei minimalinvasivem Herzeingriff
Edwards Lifesciences Herzklappen-OP US28176E1082 im Katheterlabor mit Fluoroskopie-Bildschirmen und Chirurgenteam in Aktion, Illustration mit AI erstellt.

Edwards Lifesciences stock closed at USD 89.45 on the NYSE on September 22, 2026, up 1.26 percent from the previous close. The stock gained more than the Nasdaq Composite, which rose 0.45 percent to 27,244.28 on the same session date.

September 22, 2026 in numbers

Edwards Lifesciences Inc. (ISIN US28176E1082, NYSE: EW) traded between USD 88.49 and USD 89.58 and recorded volume of 866,356 shares on September 22, 2026. The close stood USD 6.84 below the 52-week high of USD 96.29 and USD 17.15 above the 52-week low of USD 72.30.

Today before the open

The Nasdaq Composite enters the US session after reaching a record close of 27,244.28 on September 22, 2026, according to Reuters. That market backdrop is relevant to Edwards Lifesciences because its NYSE-listed shares trade within the broader US equity session.

Disclaimer...

en | US28176E1082 | EDWARDS LIFESCIENCES | boerse | 70162269 | bgmi